Türk Dağı Hatice, Ozdemir Mehmet, Baykan Mahmut, Baysal Bülent
Selçuk Üniversitesi Meram Tıp Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dalı, Konya, Türkiye.
Mikrobiyol Bul. 2010 Jul;44(3):467-72.
Human parvovirus B19 is a small, non-enveloped, icosahedral symmetric, single-stranded DNA virus that can cause a number of diseases, notably erythema infectiosum in children and aplastic crisis in patients with chronic hemolytic disorders. There have been limited data on the epidemiological pattern of parvovirus B19 infection in Turkey. The objective of this study was to investigate the seroprevalence of parvovirus B19 in Konya province (Central Anatolia), Turkey. Parvovirus B19 IgG antibodies were investigated by a commercial ELISA kit (RIDASCREEN, R-Biopharm AG, Germany) in 631 adults (age range: 18-> 60 years) and 542 children (age range: 0-17 years). The overall prevalence of parvovirus B19 IgG antibodies was 28.9%. The rate of parvovirus B19 IgG positivity was 20.7% (112/542) in the 0-17 years age group and was 36% (227/631) in the adult population. No significant difference in seropositivity rates were detected in terms of sex in children and adult group (p>0.05 in both groups). The rates of parvovirus B19 IgG seropositivity were 15.8% in 0-4 years age group, 16% in 5-9 years, 24.2% in 10-14 years, 40.9% in 15-19 years, 34.7% in 20-29 years, 35.5% in 30-39 years, 32.2% in 40-49 years, 37.5% in 50-59 years and 53.8% in > 60 years age group. The seropositivity rates in 0-4 and 5-9 years age groups were lower than the other age groups and the difference was statistically significant (p< 0.05). To determine the prevalence of parvovirus B19 in different age groups in different geographical areas is necessary since this will provide important information about the epidemiology of such infections.
人细小病毒B19是一种小型、无包膜、呈二十面体对称的单链DNA病毒,可引发多种疾病,尤其是儿童的传染性红斑和慢性溶血性疾病患者的再生障碍危象。关于土耳其细小病毒B19感染的流行病学模式的数据有限。本研究的目的是调查土耳其科尼亚省(安纳托利亚中部)细小病毒B19的血清阳性率。采用商用ELISA试剂盒(RIDASCREEN,德国R - Biopharm AG公司)对631名成年人(年龄范围:18至60岁以上)和542名儿童(年龄范围:0至17岁)进行了细小病毒B19 IgG抗体检测。细小病毒B19 IgG抗体的总体阳性率为28.9%。在0至17岁年龄组中,细小病毒B19 IgG阳性率为20.7%(112/542),在成年人中为36%(227/631)。在儿童和成人组中,按性别检测的血清阳性率无显著差异(两组p>0.05)。在0至4岁年龄组中,细小病毒B19 IgG血清阳性率为15.8%,5至9岁为16%,10至14岁为24.2%,15至19岁为40.9%,20至29岁为34.7%,30至39岁为35.5%,40至49岁为32.2%,50至59岁为37.5%,60岁以上为53.8%。0至4岁和5至9岁年龄组的血清阳性率低于其他年龄组,差异具有统计学意义(p<0.05)。确定不同地理区域不同年龄组中细小病毒B19的流行情况很有必要,因为这将提供有关此类感染流行病学的重要信息。